Jamie Clark
Stock Analyst at Rothschild & Co
(2.13)
# 2,936
Out of 5,154 analysts
9
Total ratings
57.14%
Success rate
7.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $245.86 | +26.49% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $470.59 | +0.72% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $107.20 | +120.15% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $174.46 | +4.32% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $269.67 | +2.35% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $199.21 | -2.11% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $174.49 | +58.18% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $245.86
Upside: +26.49%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $470.59
Upside: +0.72%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $107.20
Upside: +120.15%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $174.46
Upside: +4.32%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $269.67
Upside: +2.35%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $199.21
Upside: -2.11%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $174.49
Upside: +58.18%